Neohla Bio
The computed 12-month bankruptcy probability of Neohla Bio is 0.4% (very low). The 2025 annual accounts show equity of €347k and a net result of €-427k. Its solvency ranks better than 82% of 84 sector peers (fiscal year 2025). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €347k |
| Net result | €-427k |
| Better than sector | 82% |
| Active | 3 yrs |
Strong profile, led by solvency.
All 5 axes are computed from data Checked has read.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.
See plans →| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 83.2% | 46.6% | |
| Net result | €-427k | €15k | |
| Equity | €347k | €86k | |
| Gross operating margin | €-55k | €44k | |
| Total assets | €418k | €251k |
Show 8 other metrics
| Fiscal year | 2025 |
|---|---|
| Deposit | verkort |
| Revenue | - |
| EBITDA | €-55k |
| Net profit | €-427k |
| Cash flow | €-43k |
| Staff costs | - |
| Income taxes | €-13k |
| Dividends | - |
| Total assets | €418k |
| Equity | €347k |
| Debt | €70k |
| of which ≤ 1y | €70k |
| of which > 1y | - |
| Working capital | €347k |
| Employees (FTE) | - |
| 2025 | |
|---|---|
| Current ratio | 5.94 |
| Quick ratio | 5.94 |
| Working capital ratio | 83.2% |
| Solvency | 83.2% |
| Debt / equity | 0.20 |
| Long-term debt ratio | - |
| Interest coverage | -174.88 |
| Gross margin | - |
| Net margin | - |
| ROA | -102.2% |
| ROE | -122.9% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Full annual accounts (19 line items)
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €418k |
| Current assets | 29/58 | €418k |
| Amounts receivable within one year | 40/41 | €9k |
| Cash & bank | 54/58 | €357k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €418k |
| Equity | 10/15 | €347k |
| Contributions / capital | 10/11 | €1.24M |
| Accumulated profits (losses) | 14 | €-888k |
| Amounts payable | 17/49 | €70k |
| Amounts payable within one year | 42/48 | €70k |
| Trade debts payable within one year | 44 | €70k |
| Income statement | ||
| Gross operating margin | 9900 | €-55k |
| Operating result | 9901 | €-440k |
| Financial income | 75 | €0 |
| Financial charges | 65 | €316 |
| Result before taxes | 9903 | €-440k |
| Income taxes | 67/77 | €-13k |
| Net result for the period | 9904 | €-427k |
| Result to be appropriated | 9905 | €-427k |
| NACE primary | Speur- en ontwikkelingswerk op biotechnologisch gebied(72101) |
| Legal form | Limited partnership(612) |
| Incorporation | 25-04-2023 |
| Status | Active |
| Postal code | 2600 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11303B0445/00F008 | Flanders | 2,372 m² | 1 · 792 m² | 23.9 m · 7 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
We know of 4 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
17-12-2025 Capital increase of €450,000
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 450000,
"currency": "EUR",
"after_eur": null,
"delta_eur": 450000,
"before_eur": null,
"amount_type": "kapitaal_effectief",
"effective_date": "2025-10-28",
"evidence_quote": "De uitvoering van een verhoging van het eigen vermogen van Neohla Bio als volgt: Bioqube brengt een bedrag in van 450.000 EUR (vierhonderdvijftigduizend euro) in ruil voor 450.000 aandelen.",
"contribution_type": "in_kind"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0801.148.536",
"name_full": "NEOHLA BIO",
"legal_form": "CommV"
}
}09-07-2025 Registered office moved from Vosselaar to Berchem
- Roekendreef 14, 2350 Vosselaar → Uitbreidingstraat 66, 2600 Berchem
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Berchem",
"region": null,
"street": "Uitbreidingstraat",
"country": "BE",
"postcode": "2600",
"box_number": "31",
"street_number": "66"
},
"old_address": {
"city": "Vosselaar",
"region": null,
"street": "Roekendreef",
"country": "BE",
"postcode": "2350",
"box_number": null,
"street_number": "14"
},
"effective_date": "2025-03-14",
"evidence_quote": "De vergadering beslist, bij afzonderlijke stemming, de maatschappelijke zetel vanaf heden te verplaatsen naar Uitbreidingstraat 66 bus 31, 2600 Berchem."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0801.148.536",
"name_full": "FENCE BIO",
"legal_form": "CommV"
}
}05-03-2024 Registered office moved from Mechelen to Vosselaar
- Goswin de Stassartstraat 19, 2800 Mechelen → Roekendreef 14, 2350 Vosselaar
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Vosselaar",
"region": null,
"street": "Roekendreef",
"country": "BE",
"postcode": "2350",
"box_number": null,
"street_number": "14"
},
"old_address": {
"city": "Mechelen",
"region": null,
"street": "Goswin de Stassartstraat",
"country": "BE",
"postcode": "2800",
"box_number": null,
"street_number": "19"
},
"effective_date": "2023-08-31",
"evidence_quote": "Op 31 augustus 2023 heeft de beheerder Bioqube Factory Project Company CommV, vertegenwoordigd door haar vaste vertegenwoordiger Debora Dumont, beslist om de zetel van de Vennootschap met onmiddellijke ingang te verplaatsen naar de Roekendreef 14 te 2350 Vosselaar."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0801.148.536",
"name_full": "FENCE BIO",
"legal_form": "CommV"
}
}27-04-2023 Incorporation of a new CommV
Technical details
{
"kind": "oprichting",
"seat": "Goswin de Stassartstraat 19, 2800 Mechelen",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": {
"kbo": "0776.937.633",
"name": "Bioqube Factory Project Company CommV"
},
"kind": "rechtspersoon",
"person": null,
"share_class": "Ordinary",
"partner_role": null,
"holder_org_kbo": "0776.937.633",
"holder_org_name": "Bioqube Factory Project Company CommV",
"contribution_type": "cash",
"amount_paid_in_eur": 1,
"holder_person_name": null,
"is_subscriber_only": false,
"n_shares_subscribed": 1,
"amount_subscribed_eur": 1,
"is_anonymous_silent_partner": false
},
{
"org": {
"kbo": "0747.784.678",
"name": "Bioqube Factory Fund I CommV"
},
"kind": "rechtspersoon",
"person": null,
"share_class": "Ordinary",
"partner_role": null,
"holder_org_kbo": "0747.784.678",
"holder_org_name": "Bioqube Factory Fund I CommV",
"contribution_type": "cash",
"amount_paid_in_eur": 149999,
"holder_person_name": null,
"is_subscriber_only": true,
"n_shares_subscribed": 149999,
"amount_subscribed_eur": 149999,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 150000,
"subject_company": {
"kbo": "0801.148.536",
"name_full": "Fence Bio",
"legal_form": "CommV"
},
"initial_directors": [],
"incorporation_date": "2023-04-17",
"post_incorporation_mandates": []
}| Legal nameNL | Neohla Bio |